AWM
TBIO

Aevitas Wealth Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Aevitas Wealth Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,693
Closed -$58K – 376
2019
Q1 		$58K Buy
+5,693
New +$43.7K 0.05% 178

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Aevitas Wealth Management's TBIO Position: Q2 2019 in Review

Aevitas Wealth Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2019, closing a stake of 5,693 shares — an estimated $58K sold.

Aevitas Wealth Management first reported a position in TBIO in Q1 2019 and held it in 1 quarter. The position peaked at $58K in Q1 2019. 60 funds tracked by Wall St. Rank hold TBIO as of Q2 2019.

  • Aevitas Wealth Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Aevitas Wealth Management sold 5,693 Translate Bio, Inc. Common Stock shares in Q2 2019, an estimated $58K.
  • Aevitas Wealth Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Aevitas Wealth Management's Translate Bio, Inc. Common Stock position peaked at $58K in Q1 2019.
  • 60 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2019.

Based on Aevitas Wealth Management's 13F filing for Q2 2019, filed 26 Jul 2019.